Press Releases BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
5.38 ^USD	-0.37%		+0.94%	-16.98%

05-09	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
05-09	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BrainsWay : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	05-09	PU
BrainsWay : Immediate Report of Meeting	05-09	PU
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights	05-08	AQ
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024	04-24	AQ
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates	04-17	AQ
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease	04-04	AQ
BrainsWay : Report of Periodic or Interim Report	03-28	PU
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis	03-28	AQ
BrainsWay : Corporate Presentation March 2024	03-18	PU
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems	03-18	AQ
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights	03-06	AQ
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024	02-21	AQ
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology	01-10	AQ
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network	12-19	AQ
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea	12-07	AQ
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives	11-20	AQ
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights	11-15	AQ
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction	11-02	AQ
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023	11-01	AQ
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression	23-10-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Press Releases

Filters